In IBD, there is an increase in inflammatory mediators responsible for generating and maintaining inflammation in the gastrointestinal tract, including pro-inflammatory cytokines such as interleukin IL-1β, IL-6, IL-17, tumor necrosis factor (TNF-α), prostaglandins and nitric oxide (NO) [73]. The gene discussed is IL17A; the disease is inflammatory bowel disease.